Every Monday we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about…
Highlights: All Eyes on Ovarian Biology, Maternal Health on the Rise & Reinventing the Dental Dam
Why are we excited about this field? Celmatix, Oviva and others are developing therapeutics, with the potential to postpone menopause, address infertility and solve for chronic conditions such as PCOS or endometriosis by leveraging ovarian biology in different ways. So their success could truly be a gamechanger for women’s health.
Maternal health companies continue to attract fundingto bring much needed innovation to the space. Last week’s highlights included Cayaba Care raising a $12M Series A, Mahmee adding $9.2M in Series A funding, Pulsenmore inking a partnership with GE Healthcare (incl. up to $50M in funding) and biotech company Mirvie adding $60M for its RNA platform focused on early prediction of pregnancy complications.